Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
At the end of the study, final blood samples were taken, and the animals were euthanized by cardiac injection
Research has shown that AOD-9604 increases the expression of beta-3 adrenergic receptors in adipose tissue, restoring suppressed receptor levels in obese models
Our protocols are continuously refined from real-world outcomes across 40,000+ users Studied by our Stanford PhD-led Research Team in the $101M XPRIZE Healthspan competition Prescription-grade ingredients compounded by LegitScript-certified pharmacies Read our Research AgelessRx researchers are one of 40 global teams competing in the $101M XPRIZE Healthspan competition, studying B12 with other therapies to measure real-world impacts on brain, muscle, and immune system aging
Some practitioners theorize that local administration to abdominal fat may enhance regional lipolytic effects, though this has not been conclusively proven
Additionally, AOD-9604 is not FDA-approved for weight loss, and its legality varies depending on the country
Molecular Formula: CHCuNO (peptide-copper complex)
